AREB vs JEM

AREB exhibits severe financial distress, as reflected in its Piotroski F-Score of 1/9 (indicating extreme weakness) and the absence of an Altman Z-Score, which raises significant bankruptcy risk. The company reports negative profitability across all margins, a negative ROA of -48.65%, and a dangerously high debt/equity ratio of 6.66. Despite a low price of $0.14, the stock is fundamentally unsound, with a 52-week low of $0.12 and a 5-year return of -100%. The lack of analyst coverage and consistent earnings misses further underscore its poor operational and market standing.

JEM exhibits a Piotroski F-Score of 4/9, indicating a stable but mediocre financial health baseline, yet this is overshadowed by catastrophic price performance and operational failure. The company has suffered a 97.1% decline over the last year, crashing from a 52-week high of $158.00 to $0.11. While the balance sheet shows low leverage (Debt/Equity 0.08) and decent liquidity (Current Ratio 2.81), the core business is hemorrhaging cash with an operating margin of -71.57% and a devastating ROE of -133.41%. The lack of an Altman Z-Score and Graham Number reflects the absence of positive earnings, rendering traditional value metrics inapplicable.